Literature DB >> 30714958

Alzheimer's Disease Markers in Aged ApoE-PON1 Deficient Mice.

Chandrakala Aluganti Narasimhulu1, Connie Mitra1, Deepshikha Bhardwaj1, Kathryn Young Burge1, Sampath Parthasarathy1.   

Abstract

BACKGROUND: Alzheimer's disease (AD) is a neurodegenerative disorder associated with aging. Cardiovascular risk factors like hypertension and atherosclerosis increase the risk for AD. Polymorphic alleles of apolipoprotein E (ApoE) are one of the main genetic determinants of AD.
OBJECTIVE: Mice, double-knockout (DKO) for ApoE (major cholesterol carrier in brain) and PON1 (paroxonase1, reduces oxidative stress), showed severe age-dependent atherosclerosis of the arteries carrying blood to the brain even on normal diet. This prompted us to investigate the possibility of an AD pathology resulting from the deficiency of ApoE and the induction of oxidative stress.
METHODS: Atherosclerotic lesions were quantified by ImageJ. The brain hippocampus of young and old ApoE-PON1 DKO mice and control mice were harvested. RT-PCR analysis was performed for mRNA levels of AD specific markers. Blood levels of S100 calcium-binding protein B (S100B) protein were measured by ELISA. H&E as well as immunostaining was performed to detect amyloid-β (Aβ) plaques and neurofibrillary tangles (NFTs) in brain tissues. Evans blue dye was used to evaluate the vascular permeability and blood-brain barrier (BBB) dysfunction.
RESULTS: Results showed that the older DKO mice had severe carotid atherosclerosis, increased mRNA levels of AD markers in brain tissue, and elevated levels of serum S100B protein. Immunological staining confirmed the characteristics of AD. Ex-vivo imaging showed higher levels of Evans blue dye in the ApoE-PON1 DKO mice brain tissues, pointing toward impaired vasculature.
CONCLUSION: Aged ApoE-PON1 DKO mice displaying AD specific markers along with Aβ plaques, NFTs, and disrupted BBB suggests the animals are suffering from AD.

Entities:  

Keywords:  Atherosclerosis; PON1; blood-brain barrier; neurological markers

Mesh:

Substances:

Year:  2019        PMID: 30714958     DOI: 10.3233/JAD-180883

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  5 in total

1.  Integrated proteomics reveals brain-based cerebrospinal fluid biomarkers in asymptomatic and symptomatic Alzheimer's disease.

Authors:  Lenora Higginbotham; Lingyan Ping; Eric B Dammer; Duc M Duong; Maotian Zhou; Marla Gearing; Cheyenne Hurst; Jonathan D Glass; Stewart A Factor; Erik C B Johnson; Ihab Hajjar; James J Lah; Allan I Levey; Nicholas T Seyfried
Journal:  Sci Adv       Date:  2020-10-21       Impact factor: 14.136

2.  Preventive electroacupuncture ameliorates D-galactose-induced Alzheimer's disease-like inflammation and memory deficits, probably via modulating the microbiota-gut-brain axis.

Authors:  Chuan He; Zhong-Sheng Huang; Chao-Chao Yu; Xue-Song Wang; Tao Jiang; Miao Wu; Li-Hong Kong
Journal:  Iran J Basic Med Sci       Date:  2021-03       Impact factor: 2.699

Review 3.  Paraoxonase-1 as a Regulator of Glucose and Lipid Homeostasis: Impact on the Onset and Progression of Metabolic Disorders.

Authors:  Maria João Meneses; Regina Silvestre; Inês Sousa-Lima; Maria Paula Macedo
Journal:  Int J Mol Sci       Date:  2019-08-19       Impact factor: 5.923

4.  Arylesterase Activity of Paraoxonase-1 in Serum and Cerebrospinal Fluid of Patients with Alzheimer's Disease and Vascular Dementia.

Authors:  Arianna Romani; Alessandro Trentini; Wiesje M van der Flier; Tiziana Bellini; Giovanni Zuliani; Carlo Cervellati; Charlotte E Teunissen
Journal:  Antioxidants (Basel)       Date:  2020-05-25

5.  The Antioxidant Enzyme PON1: A Potential Prognostic Predictor of Acute Ischemic Stroke.

Authors:  Yuzhen Xu; Kai Wang; Qian Wang; Yihong Ma; Xueyuan Liu
Journal:  Oxid Med Cell Longev       Date:  2021-02-05       Impact factor: 6.543

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.